We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Kinase Enzyme Movement Could Be Key to Novel Cancer Drugs

News   May 16, 2018 | Original story from University of Arizona

 
Kinase Enzyme Movement Could Be Key to Novel Cancer Drugs

The inactive form (left) of the MAPK p38 enzyme moves in an uncoordinated fashion. Once the necessary molecules (blue blob and P symbols) bind, the enzyme becomes active (right) by moving in a coordinated fashion to do its job inside a cell. Credit: Senthil Ganesan, University of Arizona Department of Chemistry and Biochemistry.

 
 
 

RELATED ARTICLES

Dramatic Increase in E-Cigarette Use Among Youth

News

Sharp rise in e-cigarette use results in uptick in overall tobacco product use; prompts new, forceful steps by FDA to firmly confront and reverse youth epidemic.

READ MORE

Human Cell Atlas Study Sheds Light on Maternal-Fetal Interface

News

The first Human Cell Atlas study of early pregnancy in humans has shown how the function of the maternal immune system is affected by cells from the developing placenta.

READ MORE

Rainforest Vine Compound Starves Pancreatic Cancer Cells

News

Researchers have identified a compound from a Congolese plant that has strong "antiausterity" potential, making pancreatic cancer cells susceptible to nutrient starvation.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Analysis & Separations Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE